← Back

RC365 Holding PLC

7.50+368.8%1Y · GBX

RC365 Holding plc is an investment holding company that provides fintech solutions in Hong Kong, the United Kingdom, and Japan. Its services include IT support and security, online and offline payment gateway solutions, credit card issuance and top-up, and computer graphic design and animation. It also offers asset-linked credit card solutions, foreign exchange, media production, money lending, business virtual account support, and enterprise resource planning (ERP) services. Additional offerings include exchange, remittance, and licensed small payment services, cybersecurity and IT managed support, prepaid card advisory, regulated money services, and IT software development and payment services. The company serves multinational merchants, SMEs, and individual retail customers, and was founded in 2013 with its headquarters in London, the United Kingdom.

Price · split & dividend adjusted
News & notes moving RCGH.LSE
RCGH.LSE▲

Arrow Exploration brings Icaco-2 well on production at 830 barrels per day

Arrow Exploration Corp has brought its Icaco-2 well in Colombia on production at around 830 barrels per day gross, taking total corporate output to approximately 5,000 barrels of oil equivalent per day. CEO Marshall Abbott says the Icaco discovery may be material to Arrow, with horizontal and vertical development wells already planned. Frontier IP Group PLC has raised £4 million through a placing and subscription at 12p per share, with six directors participating in the subscription element, and a retail offer through BookBuild aims to raise a further £400,000 before closing at 5pm on 18 June. RC365 Holding PLC has signed a point-of-sale agreement with StarCruises International to deploy its RC3.0 payments platform across cruise operations in Asia, including cryptocurrency acceptance and multi-language support. Coiled Therapeutics has appointed two senior oncologists to a newly formed medical advisory board guiding its lead cancer drug AO-252 through phase I trials, with Professor Guru Sonpavde and Dr Alexander Spira shaping clinical strategy as the programme moves toward expansion cohorts in the second half of 2026. Genflow Biosciences Ltd has been invited to present results from its SLAB dog longevity study at the Animal Longevity Summit in Toronto in October, with the study evaluating its SIRT6 gene therapy in aged beagles concluding this month. Pan African Resources PLC will join the FTSE 250 from 23 June, following the court sanction of its all-share acquisition of Emmerson Resources, and also joins the FTSE 350, FTSE All-Share and related indices.
AXL.LSE · Supply · Positive Icaco-2 well brought on production at 830 bpd, boosting total output to ~5,000 boepd.
FIPP.LSE · Capital · Positive Raised £4 million via placing and subscription at 12p per share, with retail offer for additional £400,000.
GENF.LSE · Technology · Positive Invited to present SLAB dog longevity study results at Animal Longevity Summit, evaluating SIRT6 gene therapy.
PAF.LSE · Capital · Positive Will join FTSE 250 from 23 June after court sanction of Emmerson Resources acquisition.
RCGH.LSE · Demand · Positive Signed point-of-sale agreement with StarCruises to deploy RC3.0 payments platform across Asia cruise operations.
Coiled Therapeutics · Technology · Positive Appoints senior oncologists to medical advisory board guiding lead cancer drug AO-252 through phase I trials, with expansion cohorts planned.
Read original ↗
Yahoo Finance·110dRead more →